vs
DESTINATION XL GROUP, INC.（DXLG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
DESTINATION XL GROUP, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$101.9M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-6.0M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -13.8%）
Destination XL Group是北美大型男装零售商，主打大码与加肥加大男士服饰，旗下拥有DXL、Casual Male XL两大品牌，在美国全境开设了290家直营门店与 outlet 门店，同时通过dxl.com官网及移动客户端服务美国、加拿大、英国、大中华区等全球多地客户，总部位于美国马萨诸塞州坎顿。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DXLG vs PBYI — 直观对比
营收规模更大
DXLG
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出33.0%
-5.2%
自由现金流更多
PBYI
多$20.4M
$-6.0M
两年增速更快
PBYI
近两年复合增速
-13.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $101.9M | $75.5M |
| 净利润 | $-4.1M | — |
| 毛利率 | 42.7% | 69.3% |
| 营业利润率 | -5.6% | 22.7% |
| 净利率 | -4.0% | — |
| 营收同比 | -5.2% | 27.7% |
| 净利润同比 | -128.3% | — |
| 每股收益（稀释后） | $-0.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXLGPBYI
| Q4 25 | $101.9M | $75.5M | ||
| Q3 25 | $115.5M | $54.5M | ||
| Q2 25 | $105.5M | $52.4M | ||
| Q1 25 | $119.2M | $46.0M | ||
| Q4 24 | $107.5M | $59.1M | ||
| Q3 24 | $124.8M | $80.5M | ||
| Q2 24 | $115.5M | $47.1M | ||
| Q1 24 | $137.1M | $43.8M |
净利润DXLGPBYI
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $-265.0K | $8.8M | ||
| Q2 25 | $-1.9M | $5.9M | ||
| Q1 25 | $-1.3M | $3.0M | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.4M | $20.3M | ||
| Q2 24 | $3.8M | $-4.5M | ||
| Q1 24 | $5.2M | $-4.8M |
毛利率DXLGPBYI
| Q4 25 | 42.7% | 69.3% | ||
| Q3 25 | 45.2% | 77.7% | ||
| Q2 25 | 45.1% | 76.5% | ||
| Q1 25 | 44.4% | 77.1% | ||
| Q4 24 | 45.1% | 76.4% | ||
| Q3 24 | 48.2% | 63.9% | ||
| Q2 24 | 48.2% | 77.4% | ||
| Q1 24 | 47.0% | 75.5% |
营业利润率DXLGPBYI
| Q4 25 | -5.6% | 22.7% | ||
| Q3 25 | 0.6% | 17.6% | ||
| Q2 25 | -3.3% | 12.7% | ||
| Q1 25 | -1.5% | 8.7% | ||
| Q4 24 | -2.4% | 22.6% | ||
| Q3 24 | 2.5% | 27.4% | ||
| Q2 24 | 4.2% | -4.6% | ||
| Q1 24 | 5.9% | -5.3% |
净利率DXLGPBYI
| Q4 25 | -4.0% | — | ||
| Q3 25 | -0.2% | 16.2% | ||
| Q2 25 | -1.8% | 11.2% | ||
| Q1 25 | -1.1% | 6.5% | ||
| Q4 24 | -1.7% | — | ||
| Q3 24 | 1.9% | 25.2% | ||
| Q2 24 | 3.3% | -9.6% | ||
| Q1 24 | 3.8% | -11.0% |
每股收益（稀释后）DXLGPBYI
| Q4 25 | $-0.08 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.04 | $0.12 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $0.04 | $0.41 | ||
| Q2 24 | $0.06 | $-0.09 | ||
| Q1 24 | $0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $27.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $137.2M | $130.3M |
| 总资产 | $401.5M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DXLGPBYI
| Q4 25 | $27.0M | $97.5M | ||
| Q3 25 | $33.5M | $94.4M | ||
| Q2 25 | $29.1M | $96.0M | ||
| Q1 25 | $48.4M | $93.2M | ||
| Q4 24 | $43.0M | $101.0M | ||
| Q3 24 | $63.2M | $96.7M | ||
| Q2 24 | $53.2M | $96.8M | ||
| Q1 24 | $60.0M | $107.2M |
总债务DXLGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益DXLGPBYI
| Q4 25 | $137.2M | $130.3M | ||
| Q3 25 | $140.9M | $115.3M | ||
| Q2 25 | $140.7M | $104.7M | ||
| Q1 25 | $141.2M | $97.1M | ||
| Q4 24 | $145.5M | $92.1M | ||
| Q3 24 | $157.0M | $71.1M | ||
| Q2 24 | $153.6M | $48.5M | ||
| Q1 24 | $149.0M | $51.0M |
总资产DXLGPBYI
| Q4 25 | $401.5M | $216.3M | ||
| Q3 25 | $408.8M | $202.9M | ||
| Q2 25 | $380.1M | $194.9M | ||
| Q1 25 | $381.0M | $196.2M | ||
| Q4 24 | $381.3M | $213.3M | ||
| Q3 24 | $383.8M | $220.7M | ||
| Q2 24 | $376.6M | $205.0M | ||
| Q1 24 | $357.7M | $214.1M |
负债/权益比DXLGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $14.4M |
| 自由现金流率自由现金流/营收 | -5.9% | 19.1% |
| 资本支出强度资本支出/营收 | 4.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流DXLGPBYI
| Q4 25 | $-1.1M | $14.4M | ||
| Q3 25 | $9.9M | $9.7M | ||
| Q2 25 | $-12.0M | $14.1M | ||
| Q1 25 | $17.1M | $3.6M | ||
| Q4 24 | $-3.5M | $15.6M | ||
| Q3 24 | $17.1M | $11.0M | ||
| Q2 24 | $-1.1M | $1.0M | ||
| Q1 24 | $16.5M | $11.2M |
自由现金流DXLGPBYI
| Q4 25 | $-6.0M | $14.4M | ||
| Q3 25 | $4.6M | $9.7M | ||
| Q2 25 | $-18.8M | $14.1M | ||
| Q1 25 | $8.8M | $3.6M | ||
| Q4 24 | $-10.1M | $15.6M | ||
| Q3 24 | $10.2M | $11.0M | ||
| Q2 24 | $-7.0M | $1.0M | ||
| Q1 24 | $9.5M | — |
自由现金流率DXLGPBYI
| Q4 25 | -5.9% | 19.1% | ||
| Q3 25 | 3.9% | 17.7% | ||
| Q2 25 | -17.8% | 26.8% | ||
| Q1 25 | 7.4% | 7.7% | ||
| Q4 24 | -9.4% | 26.4% | ||
| Q3 24 | 8.2% | 13.7% | ||
| Q2 24 | -6.1% | 2.1% | ||
| Q1 24 | 6.9% | — |
资本支出强度DXLGPBYI
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 4.6% | 0.0% | ||
| Q2 25 | 6.4% | 0.0% | ||
| Q1 25 | 7.0% | 0.1% | ||
| Q4 24 | 6.2% | 0.0% | ||
| Q3 24 | 5.5% | 0.0% | ||
| Q2 24 | 5.1% | 0.0% | ||
| Q1 24 | 5.1% | 0.0% |
现金转化率DXLGPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.17× | 0.54× | ||
| Q2 24 | -0.30× | — | ||
| Q1 24 | 3.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXLG
| Sales Channel Through Intermediary | $74.5M | 73% |
| Sales Channel Directly To Consumer | $27.3M | 27% |
PBYI
暂无分部数据
